Clinical trials
Completed Phase 1/2 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 7 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| Eisai Inc. | 2 |
| Fuda Cancer Hospital, Guangzhou | 2 |
| Imperial College London | 2 |
| Incyte Biosciences International Sàrl | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Merck KGaA, Darmstadt, Germany | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 74 |
| Liver Neoplasms | 20 |
| Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Carcinoma, Renal Cell | 6 |
| Melanoma | 6 |
| Carcinoma | 4 |
| Colorectal Neoplasms | 4 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.